This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsiang, Y.-H. Articles by Liu, L. F. Search for Related Content PubMed PubMed Citation Articles by Hsiang, Y.-H. Articles by Liu, L. F.

Proliferation-dependent Regulation of DNA Topoisomerase II in Cultured Human Cells¹

Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

The intracellular level of DNA topoisomerase II appears to be reversibly regulated by serum concentration in cultured primary human skin fibroblasts (HSF). Upon serum starvation, the intracellular level of topoisomerase II in HSF, as monitored by immunoblotting with antitopoisomerase II antibodies, gradually decreased to a nondetectable level (less than 10⁴ copies/cell) over a period of 72 h. Addition of 10% serum to the starved cells led to a gradual increase of the intracellular topoisomerase II to the original level (approximately 10⁶ copies/cell) over a period of 24 h. The intracellular DNA topoisomerase II level in HSF is also sensitive to cell density; minimally a 7-fold decrease was observed when HSF were grown to saturation density in a constant serum concentration. Similarly, the intracellular levels of DNA topoisomerase II in other "nontransformed" cells such as mouse NIH 3T3 and 3T6 cells are also sensitive to both the serum concentration and the cell density. In contrast, topoisomerase II levels in transformed cells such as HeLa cells, L1210 cells, and SV40 T-antigen-transformed COS-1 cells are maintained at high levels (approximately 10⁶ copies/cell) and are much less sensitive to growth conditions. The topoisomerase II level in HeLa cells synchronized by a double thymidine block remained relatively constant (less than 2-fold difference) throughout the late G₁, S, G₂, and M phases of the cell cycle. Our results suggest that the level of DNA topoisomerase II is primarily regulated in the G₀-G₁ phase of the cell cycle and is elevated to a high level (approximately 10⁶ copies/cell) in proliferating cells. In contrast, the intracellular levels of DNA topoisomerase I in these cells were largely unaffected by these growth conditions either in HSF or in HeLa cells.

¹ This work was supported by NIH Grants GM-27731 and CA-96632.

² To whom requests for reprints should be addressed, at Department of Biological Chemistry, The Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD 21205.

Received 12/ 8/87. Revised 2/24/88. Accepted 3/ 3/88.

This article has been cited by other articles:

				J. E. Deweese and N. Osheroff The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing Nucleic Acids Res., February 1, 2009; 37(3): 738 - 748. [Abstract] [Full Text] [PDF]

				J. Roca Topoisomerase II: a fitted mechanism for the chromatin landscape Nucleic Acids Res., February 1, 2009; 37(3): 721 - 730. [Abstract] [Full Text] [PDF]

				C.-P. Lin, Y. Ban, Y. L. Lyu, S. D. Desai, and L. F. Liu A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes J. Biol. Chem., July 25, 2008; 283(30): 21074 - 21083. [Abstract] [Full Text] [PDF]

				L. Yan, A. Bulgar, Y. Miao, V. Mahajan, J. R. Donze, S. L. Gerson, and L. Liu Combined Treatment with Temozolomide and Methoxyamine: Blocking Apurininc/Pyrimidinic Site Repair Coupled with Targeting Topoisomerase II{alpha} Clin. Cancer Res., March 1, 2007; 13(5): 1532 - 1539. [Abstract] [Full Text] [PDF]

				Y. L. Lyu, C.-P. Lin, A. M. Azarova, L. Cai, J. C. Wang, and L. F. Liu Role of Topoisomerase II{beta} in the Expression of Developmentally Regulated Genes Mol. Cell. Biol., November 1, 2006; 26(21): 7929 - 7941. [Abstract] [Full Text] [PDF]

				A. K. McClendon, A. C. Rodriguez, and N. Osheroff Human Topoisomerase II{alpha} Rapidly Relaxes Positively Supercoiled DNA: IMPLICATIONS FOR ENZYME ACTION AHEAD OF REPLICATION FORKS J. Biol. Chem., November 25, 2005; 280(47): 39337 - 39345. [Abstract] [Full Text] [PDF]

				M. Colozza, E. Azambuja, F. Cardoso, C. Sotiriou, D. Larsimont, and M. J. Piccart Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann. Onc., November 1, 2005; 16(11): 1723 - 1739. [Abstract] [Full Text] [PDF]

				J. Yun, A. Tomida, T. Andoh, and T. Tsuruo Interaction between Glucose-regulated Destruction Domain of DNA Topoisomerase II{alpha} and MPN Domain of Jab1/CSN5 J. Biol. Chem., July 23, 2004; 279(30): 31296 - 31303. [Abstract] [Full Text] [PDF]

				Y. Ogiso, A. Tomida, S. Lei, S. Oura, and T. Tsuruo Proteasome Inhibition Circumvents Solid Tumor Resistance to Topoisomerase II-directed Drugs Cancer Res., May 1, 2000; 60(9): 2429 - 2434. [Abstract] [Full Text]

				K. Hofland, B. O. Petersen, J. Falck, K. Helin, P. B. Jensen, and M. Sehested Differential Cytotoxic Pathways of Topoisomerase I and II Anticancer Agents after Overexpression of the E2F-1/DP-1 Transcription Factor Complex Clin. Cancer Res., April 1, 2000; 6(4): 1488 - 1497. [Abstract] [Full Text]

				R. Hopfner, M. Mousli, J.-M. Jeltsch, A. Voulgaris, Y. Lutz, C. Marin, J.-P. Bellocq, P. Oudet, and C. Bronner ICBP90, a Novel Human CCAAT Binding Protein, Involved in the Regulation of Topoisomerase II{{alpha}} Expression Cancer Res., January 1, 2000; 60(1): 121 - 128. [Abstract] [Full Text]

				Q. Q. Pu and W. R. Bezwoda Induction of Alkylator (Melphalan) Resistance in HL60 Cells Is Accompanied by Increased Levels of Topoisomerase II Expression and Function Mol. Pharmacol., July 1, 1999; 56(1): 147 - 153. [Abstract] [Full Text]

				J. Falck, P. B. Jensen, and M. Sehested Evidence for Repressional Role of an Inverted CCAAT Box in Cell Cycle-dependent Transcription of the Human DNA Topoisomerase IIalpha Gene J. Biol. Chem., June 25, 1999; 274(26): 18753 - 18758. [Abstract] [Full Text] [PDF]

				Y. Kwok, Q. Zeng, and L. H. Hurley Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites PNAS, November 10, 1998; 95(23): 13531 - 13536. [Abstract] [Full Text] [PDF]

				T. L. Brandt, D. J. Fraser, S. Leal, P. M. Halandras, A. R. Kroll, and D. J. Kroll c-Myb trans-Activates the Human DNA Topoisomerase IIalpha Gene Promoter J. Biol. Chem., March 7, 1997; 272(10): 6278 - 6284. [Abstract] [Full Text] [PDF]

				R. Ishida, M. Iwai, K. L. Marsh, C. A. Austin, T. Yano, M. Shibata, N. Nozaki, and A. Hara Threonine 1342in Human Topoisomerase IIalpha Is Phosphorylated Throughout the Cell Cycle J. Biol. Chem., November 22, 1996; 271(47): 30077 - 30082. [Abstract] [Full Text] [PDF]

				D. A. Burden, P. S. Kingma, S. J. Froelich-Ammon, M.-A. Bjornsti, M. W. Patchan, R. B. Thompson, and N. Osheroff Topoisomerase II·Etoposide Interactions Direct the Formation of Drug-induced Enzyme-DNA Cleavage Complexes J. Biol. Chem., November 15, 1996; 271(46): 29238 - 29244. [Abstract] [Full Text] [PDF]

				T. Nakajima, K. Morita, N. Ohi, T. Arai, N. Nozaki, A. Kikuchi, F. Osaka, F. Yamao, and K. Oda Degradation of Topoisomerase IIalpha during Adenovirus E1A-induced Apoptosis Is Mediated by the Activation of the Ubiquitin Proteolysis System J. Biol. Chem., October 4, 1996; 271(40): 24842 - 24849. [Abstract] [Full Text] [PDF]

				R. Brooks and D. Winton Determination of spatial patterns of DNA damage and repair in intestinal crypts by multi-cell gel electrophoresis J. Cell Sci., January 8, 1996; 109(8): 2061 - 2068. [Abstract] [PDF]